Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,000
Closed -$1.03M 798
2020
Q1
$1.03M Hold
20,000
0.01% 483
2019
Q4
$1.36M Buy
+20,000
New +$1.25M 0.01% 612
2018
Q4
Sell
-1,250
Closed -$305K 752
2018
Q3
$305K Buy
+1,250
New +$289K ﹤0.01% 684
2017
Q4
Sell
-2,508
Closed -$239K 996
2017
Q3
$239K Buy
+2,508
New +$242K ﹤0.01% 1028

Other funds holding INGN

Natixis's INGN Position: Q2 2020 in Review

Natixis sold out of Inogen (INGN) in Q2 2020, closing a stake of 20,000 shares — an estimated $1.03M sold.

Natixis first reported a position in INGN in Q3 2017 and held it in 4 quarters. The position peaked at $1.36M in Q4 2019. 165 funds tracked by Wall St. Rank hold INGN as of Q2 2020.

  • Natixis reported no remaining Inogen position as of Q2 2020 after selling out during the quarter.
  • Natixis sold 20,000 Inogen shares in Q2 2020, an estimated $1.03M.
  • Natixis first reported a position in Inogen in Q3 2017 and held it in 4 quarters.
  • Natixis's Inogen position peaked at $1.36M in Q4 2019.
  • 165 funds tracked by Wall St. Rank held Inogen as of Q2 2020.

Based on Natixis's 13F filing for Q2 2020, filed 13 Aug 2020.